Dual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo Transfer | MicrobiomeTrials← Back to trialsNCT07811895
Dual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo Transfer
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-09Est. Completion: 2029-12
Enrollment target: 1,510 participants Locations- RenJi Hospital, Shanghai, Shanghai Municipality, China
Other microbiome trials you might be interested in
Grade 1 Endometrial Endometrioid CarcinomaEndometrial Intraepithelial NeoplasiaMetabolic Comorbidities
This single-arm study will evaluate the feasibility, safety, and preliminary efficacy of tirzepatide in combination with…
Hershey, United StatesEst. completion May 1, 2028
Obesity (BMI > 35) and Diabetes MellitusObesity (BMI > 35) and DyslipemiaObesity (BMI > 35) and High Blood Pressure
This study compares three preoperative strategies before one anastomosis gastric bypass(OAGB) for severe obesity. Partic…
Naples, Italy
Est. completion Jul 1, 2029